HA
Haw Par Corporation Limited
HAWPY · OTC
$53.50 +0.00% (+$0.00)
Market Cap $3.78B
P/E Ratio 14.46x
Div. Yield 2.34%
ROE 6.05%
Bulios Fair Price
$70.64
32.0% upside
Current Price
$53.5
Undervalued Fair Value Overvalued
According to Bulios Fair Price, HAWPY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
58 /100
Fair EV/EBITDA 41.94x
P/S 16.70x
P/B 0.88x
Growth
79 /100
Growing Rev. growth 7.51%
FCF growth 132.01%
Book val. growth 6.53%
Profitability
100 /100
Strong Net margin 115.44%
Op. margin 29.17%
FCF margin 117.05%
Quality
18 /100
Poor ROE 6.05%
ROA 5.91%
Asset turnover 0.05x
Debt
100 /100
Low Current ratio 7.13x
Int. coverage 44.05x
Net debt/EBITDA -10.33x
Stability
59 /100
Moderate Rev. volatility 17.69%
EPS volatility 21.56%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about HAWPY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Ee Lim Wee
Employees
595
Headquarters
Singapore